Addex Therapeutics Ltd (ADXN) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Addex Therapeutics Ltd

    NASDAQ: ADXN · Real-Time Price · USD
    9.44
    0.40 (4.48%)
    At close: Sep 26, 2025, 1:16 PM

    Addex Therapeutics Ltd Income Statement

    Financials in CHF. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 404.1K 1.61M 1.42M 2.92M
    Cost of Revenue
    		 854.3K 6.94M 14.62M 12.82M
    Gross Profit
    		 -444.26K -5.32M -13.2M -9.9M
    Operating Income
    		 -2.76M -10.28M -20.52M -15.51M
    Interest Income
    		 9.16K 63.96K 29.25K 5.32K
    Pretax Income
    		 -4.91M -10.56M -20.8M -15.35M
    Net Income
    		 7.06M -10.56M -20.8M -15.35M
    Selling & General & Admin
    		 1.68M 4.99M 7.3M 5.14M
    Research & Development
    		 854.3K 6.96M 14.67M 12.84M
    Other Expenses
    		 n/a -6.96M -22.52K 444K
    Operating Expenses
    		 2.31M 4.99M 21.94M 18.42M
    Interest Expense
    		 3.55K 21.61K 48.9K 63.01K
    Selling & Marketing Expenses
    		 n/a -2.21M n/a n/a
    Cost & Expenses
    		 3.16M 11.89M 21.94M 18.42M
    Income Tax Expense
    		 n/a n/a 123.91K 116.38K
    Shares Outstanding (Basic)
    		 817.61K 619.23K 376.54K 284.33K
    Shares Outstanding (Diluted)
    		 817.61K 619.23K 376.54K 284.33K
    EPS (Basic)
    		 8.40 -16.8 -55.2 -54
    EPS (Diluted)
    		 8.40 -16.8 -55.2 -54
    EBITDA
    		 -4.65M -10.23M -20.23M -14.94M
    EBIT
    		 -4.91M -10.53M -20.76M -15.29M
    Depreciation & Amortization
    		 260.12K 305.95K 323.14K 347.61K

    Add to Watchlist